CPIX vs KEY · rev $10.4M vs P/E 13, rev $7.51B
Cumberland Pharmaceuticals Inc (CPIX) versus KeyCorp (KEY) — a side-by-side from cached financials, not a winner call.
Cumberland Pharmaceuticals Inc (CPIX) is a drug manufacturers - specialty & generic company listed on US.
KeyCorp (KEY) is a banks - regional company listed on US.
Latest reported CPIX revenue for 2024-12-31 was $10.4M. Net income was -$1.9M. Revenue was up 14.9% from 2024-09-30 to 2024-12-31. CPIX currently screens at market cap $86.9M.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
CPIX currently screens at market cap $86.9M. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Not investment advice. Open the CPIX and KEY stock pages for the full models.
Not investment advice.